Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth R Bauer

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Infectious Diseases and Therapy|August 20, 2014
Amikacin pharmacokinetics during continuous veno-venous hemodialysisSimon W Lam, Seth R Bauer
Hospital Pharmacy|May 15, 2024
Initial Care for Patients with Severe Sepsis and Septic Shock: The Next ICU Quality MeasureSarah C Welch, Seth R Bauer
Critical Care (London, England)|October 17, 2025
Norepinephrine formulation itself does not constitute heterogeneity in shock trialsPatrick M Wieruszewski, Seth R Bauer
Pharmacotherapy|September 30, 2010
Arginine vasopressin for the treatment of septic shock in adultsSeth R Bauer, Simon W Lam
Pharmacotherapy|October 12, 2023
Comment on "Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study"Patrick M Wieruszewski, Seth R Bauer
Chest|July 21, 2023
Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative ReviewGretchen L Sacha, Seth R Bauer
Critical Care Medicine|July 1, 2024
Costs and Resources Must Impact Clinical Decision-Making in the ICU: The Case of Vasopressor UseSeth R Bauer, John W Devlin
Critical Care Medicine|December 5, 2024
The authors replySeth R Bauer, John W Devlin
Critical Care (London, England)|February 13, 2015
Beyond the evidence: treating pulmonary hypertension in the intensive care unitSeth R Bauer, Adriano R Tonelli
Hospital Pharmacy|March 28, 2020
Corticosteroids for Septic Shock: Another Chapter in the SagaJason Yerke, Kyle Strnad, Seth R Bauer
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Infectious Diseases and Therapy|August 20, 2014
Amikacin pharmacokinetics during continuous veno-venous hemodialysisSimon W Lam, Seth R Bauer
Hospital Pharmacy|May 15, 2024
Initial Care for Patients with Severe Sepsis and Septic Shock: The Next ICU Quality MeasureSarah C Welch, Seth R Bauer
Critical Care (London, England)|October 17, 2025
Norepinephrine formulation itself does not constitute heterogeneity in shock trialsPatrick M Wieruszewski, Seth R Bauer
Pharmacotherapy|September 30, 2010
Arginine vasopressin for the treatment of septic shock in adultsSeth R Bauer, Simon W Lam
Pharmacotherapy|October 12, 2023
Comment on "Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study"Patrick M Wieruszewski, Seth R Bauer
Chest|July 21, 2023
Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative ReviewGretchen L Sacha, Seth R Bauer
Critical Care Medicine|July 1, 2024
Costs and Resources Must Impact Clinical Decision-Making in the ICU: The Case of Vasopressor UseSeth R Bauer, John W Devlin
Critical Care Medicine|December 5, 2024
The authors replySeth R Bauer, John W Devlin
Critical Care (London, England)|February 13, 2015
Beyond the evidence: treating pulmonary hypertension in the intensive care unitSeth R Bauer, Adriano R Tonelli
Hospital Pharmacy|March 28, 2020
Corticosteroids for Septic Shock: Another Chapter in the SagaJason Yerke, Kyle Strnad, Seth R Bauer
Pageof 12